Your Trusted Source for Canadian News and Insights

Search keyWord:

HomeSearch

Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities

SINGAPORE,Feb. 13,2025-- Cloud4C,a global leader in AI-driven cloud and cybersecurity services,has achieved two prestigious AI specializations on Microsoft Azure: \'AI Platform on Microsoft Azure\' an

Feb 14, 2025
News

Aker Horizons ASA: Fourth-quarter results 2024

FORNEBU,Norway,Feb. 13,2025-- Aker Horizons ASA (OSE:AKH),a developer of green energy and industry,today announced results for the fourth quarter 2024. Aker Horizons\' net capital employed stood at NO

Feb 14, 2025
Hockey

Webull Masters 2025 Kicks Off: an Exciting Stock Trading Competition in Thailand with Over THB170,000 in Prizes

BANGKOK,Feb. 13,2025-- Webull Securities (Thailand) Co. Ltd. ("Webull Thailand"),the Thai subsidiary of Webull Corporation ("Webull"),a leading global digital investment platform,

Feb 14, 2025
Economy

Schwab Makes Expanded 24-Hour Trading Available to All Clients

Overnight trading of all S&P 500®,Nasdaq-100® stocks and hundreds of ETFs is now available to all Schwab clients via the thinkorswim® platform suite

Feb 14, 2025
Hockey

CRIMSONLOGIC AND BDO SINGAPORE SIGN STRATEGIC PARTNERSHIP TO DEVELOP SPECIALIZED GENERATIVE AI ADVISORY PLATFORM

This strategic partnership aims to transform professional advisory services by leveraging cutting-edge Generative AI to provide accurate,domain-specific insights

Feb 14, 2025
Maple Syrup

Fujitsu to offer Fujitsu Cloud Service Generative AI Platform for secure and flexible enterprise data management

KAWASAKI,Japan,Feb. 13,2025-- Fujitsu today announced the launch of theFujitsu Cloud Service Generative AI Platform. The new service,which combines data confidentiality with the ease of use of the clo

Feb 14, 2025
Hockey

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

Feb 14, 2025
News

Happy Chinese New Year 2025: Jiangsu's Intangible Cultural Heritage Takes the Global Spotlight

NANJING,China,Feb. 13,2025-- On December 4th,2024,UNESCO inscribed the "Spring Festival,Social Practices of the Chinese People in Celebration of Traditional New Year" on its Representative L

Feb 14, 2025
Social

Study Results Abstracts From Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) At 2025 ASCO Genitourinary Cancers Symposium

CHENGDU,China,Feb. 13,2025-- At the American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium 2025,to be held in San Francisco,USA,from Feb. 13-15,2025,Sichuan Kelun-Biotech Bi

Feb 14, 2025
Economy

The 137th Canton Fair Hosts Promotion Events in Southeast Asia, Bridging Trade and International Exchanges

GUANGZHOU,China,Feb. 13,2025-- As China\'s No.1 platform for international trade,the 137th Canton Fair has successfully hosted a Southeast Asiaroadshow with trade promotion events in Vietnam,Laos and

Feb 14, 2025
Depth
1 ... 447 448 449 450 451 452 453 ... 612